In this study, we investigated the hypothesis that the nuclear receptor PPARα may be involved in the beneficial activities of palmitoleic acid in attenuating the development of HFD-induced hepatic steatosis and inflammation and disruptions of glucose homeostasis. Here, PPARA is linked to fatty liver disease.